A new study reports the findings of the functional evaluation of six AAV vectors in 12 preclinical models of the human liver. The study, which aimed to uncover which combination of models is the most relevant for the identification of an AAV capsid variant for safe and efficient gene therapy to primary human hepatocytes, is published in Human Gene Therapy.
Leave A Comment